Unlike earlier compounds that target one or two pathways, Retatrutide was designed to influence multiple metabolic mechanisms at the same time
Methods: Scoping review of the international published articles following the Arksey and OMalley framework, cross-sectional studies, clinical and pre-clinical studies, systematic and umbrella reviews and grey literatures published from 2014 to 2024 with all age patient populations were included
Retatrutide, an innovative agent undergoing Phase III trials for obesity, T2DM, and non-alcoholic fatty liver disease, has demonstrated encouraging outcomes
What this means is that Wegovy mimics the naturally occurring GLP-1 hormone that is released by our intestines into our bloodstream within minutes after we ingest food
LillyDirect Zepbound vials run ~$499/mo self-pay ~$5,988/year